These keynote webinars focus on learning from national academic and regulatory experts practical knowledge to apply to your next field, secondary data or hybrid observational study for safety, HEOR/market access, drug development and marketing.
Topics of each country includes:
• Structure of healthcare
• Clinical practice patterns
• Data sources
• Strengths and limitations for observational studies
• How to overcome challenges for secondary data sources and field studies and use of innovative methodologies for different therapeutic areas, patient groups (e.g. pregnancy outcomes, children), drugs and vaccines.